Evidence map›Paper›PMID 33753817›Full record

ArticleScientific reports2021

Analysis of false-negative rapid diagnostic tests for symptomatic malaria in the Democratic Republic of the Congo.

Jonathan B Parr, Eddy Kieto, Fernandine Phanzu, Paul Mansiangi, Kashamuka Mwandagalirwa, Nono Mvuama, Ange Landela, Joseph Atibu, Solange Umesumbu Efundu, Jean W Olenga and 12 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Challenges in Malaria Diagnosis and Treatment in Kinshasa Province, Democratic Republic of the Congo.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Population genomics ofbioRxiv : the preprint server for biology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 3 countries.

Jonathan B Parr *Division of Infectious Diseases, Institute for Global Health and Infectious Diseases, University of North Carolina, 130 Mason Farm Rd, Chapel Hill, NC, 27599, USA. jonathan_parr@med.unc.edu.
Eddy Kieto *SANRU Asbl (Sante Rurale/Global Fund), Kinshasa, Democratic Republic of the Congo.
Fernandine PhanzuSANRU Asbl (Sante Rurale/Global Fund), Kinshasa, Democratic Republic of the Congo.
Paul MansiangiUniversity of Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
Kashamuka MwandagalirwaUniversity of Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
Nono MvuamaUniversity of Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
Ange LandelaInstitut National Pour La Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
Joseph AtibuUniversity of Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
Solange Umesumbu EfunduProgramme National de La Lutte Contre Le Paludisme, Kinshasa, Democratic Republic of Congo.
Jean W OlengaSANRU Asbl (Sante Rurale/Global Fund), Kinshasa, Democratic Republic of the Congo.
Kyaw Lay ThwaiDivision of Infectious Diseases, Institute for Global Health and Infectious Diseases, University of North Carolina, 130 Mason Farm Rd, Chapel Hill, NC, 27599, USA.
Camille E MorganDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, 27599, USA.
Madeline DentonDivision of Infectious Diseases, Institute for Global Health and Infectious Diseases, University of North Carolina, 130 Mason Farm Rd, Chapel Hill, NC, 27599, USA.
Alison PoffleyDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, 27599, USA.
Jonathan J JulianoDivision of Infectious Diseases, Institute for Global Health and Infectious Diseases, University of North Carolina, 130 Mason Farm Rd, Chapel Hill, NC, 27599, USA.
Pomie MungalaSANRU Asbl (Sante Rurale/Global Fund), Kinshasa, Democratic Republic of the Congo.
Joris L LikwelaSANRU Asbl (Sante Rurale/Global Fund), Kinshasa, Democratic Republic of the Congo.
Eric M SompweProgramme National de La Lutte Contre Le Paludisme, Kinshasa, Democratic Republic of Congo.
Eric RogierMalaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, 30033, USA.
Antoinette K TshefuUniversity of Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
Adrien N'SialaSANRU Asbl (Sante Rurale/Global Fund), Kinshasa, Democratic Republic of the Congo.
Albert KalonjiSANRU Asbl (Sante Rurale/Global Fund), Kinshasa, Democratic Republic of the Congo.
Global Fund to Fight AIDS, Tuberculosis and Malaria · CHUniversity of North Carolina at Chapel Hill · USUniversity of Kinshasa · CDProgramme National Multisectoriel de Lutte contre le sida · CDDivision of Parasitic Diseases and Malaria · USNational Institute of Biomedical Research · CD

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008719 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DARVILLE, TONI, DESHMUKH, MOHANISH P · 1999 to 2023
$15.1M
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of AlternativesR01AI132547 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DINGLASAN, RHOEL DAVID RAMOS, JULIANO, JONATHAN J · 2018 to 2022
$3.6M
Development of novel diagnostics for African non-falciparum malariaR21AI148579 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIN, JESSICA, PARR, JONATHAN BOYD · 2020 to 2021
$420k
NIAID NIH HHS R01 AI132547NIAID NIH HHS R21 AI148579NIGMS NIH HHS T32 GM008719
6 · The paper itself

Abstract

The majority of Plasmodium falciparum malaria diagnoses in Africa are made using rapid diagnostic tests (RDTs) that detect histidine-rich protein 2. Increasing reports of false-negative RDT results due to parasites with deletions of the pfhrp2 and/or pfhrp3 genes (pfhrp2/3) raise concern about existing malaria diagnostic strategies. We previously identified pfhrp2-negative parasites among asymptomatic children in the Democratic Republic of the Congo (DRC), but their impact on diagnosis of symptomatic malaria is unknown. We performed a cross-sectional study of false-negative RDTs in symptomatic subjects in 2017. Parasites were characterized by microscopy; RDT; pfhrp2/3 genotyping and species-specific PCR assays; a bead-based immunoassay for Plasmodium antigens; and/or whole-genome sequencing. Among 3627 symptomatic subjects, 427 (11.8%) had RDT-/microscopy + results. Parasites from eight (0.2%) samples were initially classified as putative pfhrp2/3 deletions by PCR, but antigen testing and whole-genome sequencing confirmed the presence of intact genes. 56.8% of subjects had PCR-confirmed malaria. Non-falciparum co-infection with P. falciparum was common (13.2%). Agreement between PCR and HRP2-based RDTs was satisfactory (Cohen's kappa = 0.66) and superior to microscopy (0.33). Symptomatic malaria due to pfhrp2/3-deleted P. falciparum was not observed. Ongoing HRP2-based RDT use is appropriate for the detection of falciparum malaria in the DRC.

Indexed as

AdolescentAntigens, ProtozoanChildFalse Negative ReactionsHumansMalariaMolecular Diagnostic TechniquesPlasmodium falciparumPolymerase Chain ReactionProtozoan ProteinsReagent Kits, DiagnosticSerologic TestsAntigens, ProtozoanHRP3 protein, Plasmodium falciparumProtozoan ProteinsReagent Kits, Diagnostic

Identifiers

PMID33753817
PMCPMC7985209
OpenAlexW3136616067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.